Find Soticlestat manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Ov935, 1429505-03-2, Tak-935, Soticlestat [inn], Soticlestat [usan], Ov-935
Molecular Formula
C23H23N3O2
Molecular Weight
373.4  g/mol
InChI Key
XKUZMIUSBMCVPP-UHFFFAOYSA-N
FDA UNII
1766MU795L

Soticlestat
1 2D Structure

Soticlestat

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(4-benzyl-4-hydroxypiperidin-1-yl)-(2-pyridin-4-ylpyridin-3-yl)methanone
2.1.2 InChI
InChI=1S/C23H23N3O2/c27-22(20-7-4-12-25-21(20)19-8-13-24-14-9-19)26-15-10-23(28,11-16-26)17-18-5-2-1-3-6-18/h1-9,12-14,28H,10-11,15-17H2
2.1.3 InChI Key
XKUZMIUSBMCVPP-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1CN(CCC1(CC2=CC=CC=C2)O)C(=O)C3=C(N=CC=C3)C4=CC=NC=C4
2.2 Other Identifiers
2.2.1 UNII
1766MU795L
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (4-benzyl-4-hydroxy-1-piperidinyl)(2,4'-bipyridin-3-yl)methanone

2. Ov-935

3. Ov935

2.3.2 Depositor-Supplied Synonyms

1. Ov935

2. 1429505-03-2

3. Tak-935

4. Soticlestat [inn]

5. Soticlestat [usan]

6. Ov-935

7. Tak935

8. Soticlestat (usan)

9. 1766mu795l

10. (4-benzyl-4-hydroxypiperidin-1-yl)-(2-pyridin-4-ylpyridin-3-yl)methanone

11. [4-oxidanyl-4-(phenylmethyl)piperidin-1-yl]-(2-pyridin-4-ylpyridin-3-yl)methanone

12. Soticlestat [usan:inn]

13. Chembl4298172

14. Schembl14841089

15. Unii-1766mu795l

16. Gtpl11517

17. Who 10844

18. Hy-109123

19. Cs-0078356

20. D11590

21. (4-benzyl-4-hydroxypiperidin-1-yl) (2,4'-bipyridin-3-yl)methanone

22. (4-benzyl-4-hydroxypiperidin-1-yl)(2,4'-bipyridin-3-yl)methanone

23. [2,4'-bipyridin]-3-yl(4-benzyl-4-hydroxypiperidin-1-yl)methanone

24. 2,4'-bipyridin-3-yl(4-benzyl-4-hydroxypiperidin-1-yl)methanone

25. Ybs

2.4 Create Date
2014-04-21
3 Chemical and Physical Properties
Molecular Weight 373.4 g/mol
Molecular Formula C23H23N3O2
XLogP32.5
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count4
Rotatable Bond Count4
Exact Mass373.17902698 g/mol
Monoisotopic Mass373.17902698 g/mol
Topological Polar Surface Area66.3 Ų
Heavy Atom Count28
Formal Charge0
Complexity506
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Treatment of Chromosome 15q Duplication Syndrome, Treatment of Cyclin-Dependent Kinase-Like 5 deficiency disorder


Treatment of Dravet syndrome, Treatment of Lennox-Gastaut syndrome


Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty